TipRanks
Grace Therapeutics (GRCE)
NASDAQ:GRCE
US Market
GRCE
Grace Therapeutics
RESEARCH TOOLSreports
Want to see GRCE full AI Analyst Report?

Grace Therapeutics (GRCE) Income Statement

1,206 Followers

Grace Therapeutics Income Statement

Last quarter (Q1 2027), Grace Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Grace Therapeutics's net income was C$-15.79M. See Grace Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.08M$ 23.75M$ 17.44M$ 70.54M$ 19.48M
Depreciation and Amortization
$ 7.00K$ 9.97K$ 54.28K$ 167.71K$ 0.00
EBITDA
$ -11.07M$ -23.74M$ -15.37M$ -24.51M$ -19.17M
Operating Income
$ -11.08M$ -23.75M$ -17.44M$ -70.54M$ -19.48M
Other Income/Expenses
$ 1.58M$ 5.57M$ -2.49M$ 248.87K$ 6.40M
Pretax Income
$ -9.49M$ -18.18M$ -19.93M$ -70.29M$ -13.08M
Net Income
$ -7.79M$ -13.63M$ -17.44M$ -57.39M$ -12.27M
Per Share Metrics
Basic EPS
$ -0.47$ -1.13$ -1.83$ -7.72$ -2.02
Diluted EPS
$ -0.47$ -1.13$ -1.83$ -7.72$ -2.02
Weighted Average Shares Outstanding
 16.51M 12.09M 9.53M 7.44M 6.14M
Weighted Average Shares Outstanding (Diluted)
 16.51M 12.09M 9.53M 7.44M 6.14M

Grace Therapeutics Earnings and Revenue History